Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 142
Selected: 0
NCT IDTitle
NCT03325218Survival Expectations and Hope Among Cancer Patients at End-of-Life
NCT01716689Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas
NCT06977360Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal
NCT00486213Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
NCT04303403Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
NCT01135056Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)
NCT02736305Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
NCT06194084Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers
NCT03091491Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
NCT02720926Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer
NCT03200730A Novel Family Dignity Intervention (FDI) for Asian Palliative Care
NCT02420067Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients
NCT05286437Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
NCT07583979Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for Integration
NCT04072107EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)
NCT07626814Increasing Uptake of Cascade Testing in Families With Familial Cancer Syndromes: A Randomized Controlled Trial of a Registry-aided Model.
NCT02143388Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT07428655Acceptability and Feasibility of PSC Model of Serious Illness Communication
NCT04230330Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
NCT05724264SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)
NCT03422432Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT06587295Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy
NCT03711422Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
NCT00467194Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT04027647Phase 2 Study of Dacomitinib in NSCLC
NCT02808091Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma
NCT02408497Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy
NCT00957086Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
NCT04961632Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
NCT06160843Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
NCT05377034Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
NCT03429972Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
NCT03792867Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
NCT04104113Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial
NCT04620954Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT01100801A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients
NCT00801411Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
NCT07234357Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
NCT07111130Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
NCT01736410A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT01865838A Study Into the Effect of Seprafilm in Open Total Thyroidectomy
NCT06294808Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
NCT01309607Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer
NCT06418412A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
NCT07733973Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer
NCT06172595FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma
NCT04632173Head and Neck cancERs International cOviD-19 collabOraTion
NCT06044441Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)
NCT03233360Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
NCT01570296A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR